Exciting Breast Cancer News

Amy Hendel Health Guide
  • With October being "Breast Cancer Awareness" month, here are the headlines of some of the news coming down the pipeline.  I'll explore some of these topics next week in depth:

     

    (1) Researchers are now realizing that women take charge of their breast cancer in different ways - depending on their "coping style."  Obviously this can help the team involved in diagnosis and care more aware of different ways to disseminate their opinions and the treatment plan.

     

    (2) A new test may soon be available that allows a few drops of urine on a dipstick to indicate risk for breast cancer, long before it actually develops or becomes a life-threatening illness.

    Add This Infographic to Your Website or Blog With This Code:

     

    (3) New information will soon be released that evaluates the results of a radiation treatment.  A small whisk-like, expandable device is inserted inside the breast and helps to spare healthy nearby tissue from radiation treatments to the breast cancer.

     

    (4) The Contura Applicator is a new treatment option in the menu of "partial breast radiation treatment" that reduces treatment time from months to days!!!  Houston's Methodist Hospital was the testing center.

     

    (5) Researchers are now looking to see if partial breast radiation over a 3 week period is superior to full breast radiation, and whether 3 weeks is enough when compared to 6 weeks of treatment.

     

    (6) Researchers are looking at the relationship between exercise, weight, insulin levels, and the risk of breast cancer.

     

    (7) We know that when breast cancer hits at a young age (under age 40 or even 35), it tends to be aggressive and formidable.  Researchers are looking at the heightened psychosocial impact of a breast cancer diagnosis on these young women patients.

     

    (8) There is talk of creating a new DNA database of breast cancer occurrence statistics based on saliva tests.

     

    (9) A new grant by the US Dept. of Defense has been granted to resarchers at the University of Arkansas Medical Sciences Center to study fibroblast activation protein-alpha (FAP) and its role in breast cancer metastasis.

Published On: October 01, 2008